230
Views
2
CrossRef citations to date
0
Altmetric
Articles

Urinary Isoflavones Levels in Relation to Serum Thyroid Hormone Concentrations in Female and Male Adults in the U.S. General Population

, , , , , & show all
Pages 389-400 | Received 23 Jul 2019, Accepted 01 Sep 2019, Published online: 06 Sep 2019

References

  • Acharjee S, Zhou J-R, Elajami TK, Welty FK. 2015. Effect of soy nuts and equol status on blood pressure, lipids and inflammation in postmenopausal women stratified by metabolic syndrome status. Metab Clin Exp. 64(2):236–243. doi:10.1016/j.metabol.2014.09.005.
  • Adlercreutz H, Mazur W. 1997. Phyto-oestrogens and western diseases. Ann Med. 29(2):95–120. doi:10.3109/07853899709113696.
  • Ain KB, Mori Y, Refetoff S. 1987. Reduced Clearance Rate of Thyroxine-Binding Globulin (TBG) with increased sialylation: A mechanism for estrogen-induced elevation of serum TBG concentration*. J Clin Endocrinol Metab. 65(4):689–696. doi:10.1210/jcem-65-4-689.
  • Akaza H, Miyanaga N, Takashima N, Naito S, Hirao Y, Tsukamoto T, Fujioka T, Mori M, Kim W-J, Song JM, et al. 2004. Comparisons of percent equol producers between prostate cancer patients and controls: case-controlled studies of isoflavones in Japanese, Korean and American Residents. Jpn J Clin Oncol. 34(2):86–89. doi:10.1093/jjco/hyh015.
  • Alves RC, Almeida IMC, Casal S, Oliveira MBPP. 2010. Method development and validation for isoflavones quantification in coffee. Food Chem. 122(3):914–919. doi:10.1016/j.foodchem.2010.03.061.
  • Atkinson C, Berman S, Humbert O, Lampe JW. 2004. In vitro incubation of human feces with daidzein and antibiotics suggests interindividual differences in the bacteria responsible for equol production. J Nutr. 134(3):596–599. doi:10.1093/jn/134.3.596.
  • Atkinson C, Frankenfeld CL, Lampe JW. 2005. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med. 230(3):155–170. doi:10.1177/153537020523000302.
  • Atkinson C, Skor HE, Fitzgibbons ED, Scholes D, Chen C, Wähälä K, Schwartz SM, Lampe JW. 2002. Overnight urinary isoflavone excretion in a population of women living in the United States, and its relationship to isoflavone intake. Cancer Epidemiol Biomarkers Prev. 11(3):253–260.
  • Barr DB, Wilder LC, Caudill SP, Gonzalez AJ, Needham LL, Pirkle JL. 2005. Urinary creatinine concentrations in the U.S. Population: implications for urinary biologic monitoring measurements. Environ Health Perspect. 113(2):192–200. doi:10.1289/ehp.7337.
  • Bitto A, Polito F, Atteritano M, Altavilla D, Mazzaferro S, Marini H, Adamo EB, D’Anna R, Granese R, Corrado F, et al. 2010. Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 95(6):3067–3072. doi:10.1210/jc.2009-2779.
  • Dai Q, Franke AA, Jin F, Shu X-O, Hebert JR, Custer LJ, Cheng J, Gao Y-T ZW. 2002. Urinary excretion of phytoestrogens and risk of breast cancer among Chinese women in Shanghai. Cancer Epidemiol Biomarkers Prev. 11(9):815–821.
  • Dillingham BL, McVeigh BL, Lampe JW, Duncan AM. 2007. Soy protein isolates of varied isoflavone content do not influence serum thyroid hormones in healthy young men. Thyroid. 17(2):131–137. doi:10.1089/thy.2006.0206.
  • DiVall SA. 2013. The influence of endocrine disruptors on growth and development of children. Current Opin Endocrinol Diabetes and Obesity. 20(1):50. doi:10.1097/MED.0b013e32835b7ee6.
  • Divi RL, Chang HC, Doerge DR. 1997. Anti-thyroid isoflavones from soybean: isolation, characterization, and mechanisms of action. Biochem Pharmacol. 54(10):1087–1096. doi:10.1016/S0006-2952(97)00301-8.
  • Divi RL, Doerge DR. 1996. Inhibition of thyroid peroxidase by dietary flavonoids. Chem Res Toxicol. 9(1):16–23. doi:10.1021/tx950076m.
  • Dixon RA, Ferreira D. 2002. Genistein. Phytochemistry. 60(3):205–211. doi:10.1016/S0031-9422(02)00116-4.
  • Doerge DR, Sheehan DM. 2002. Goitrogenic and estrogenic activity of soy isoflavones. Environ Health Perspect. 110(Suppl 3):349–353. doi:10.1289/ehp.02110s5883.
  • Duncan AM, Underhill KEW, Xu X, LaValleur J, Phipps WR, Kurzer MS. 1999. Modest hormonal effects of soy isoflavones in postmenopausal women. J Clin Endocrinol Metab. 84(10):3479–3484. doi:10.1210/jcem.84.10.6067.
  • Franke AA, Custer LJ. 1994. High-performance liquid chromatographic assay of isoflavonoids and coumestrol from human urine. J. Chromatogr. B. 662(1):47–60. doi:10.1016/0378-4347(94)00390-4.
  • Gilbert ME, Rovet J, Chen Z, Koibuchi N. 2012. Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences. NeuroToxicology. 33(4):842–852. doi:10.1016/j.neuro.2011.11.005.
  • Hamilton-Reeves JM, Rebello SA, Thomas W, Kurzer MS, Slaton JW. 2007. Effects of soy protein isolate consumption on prostate cancer biomarkers in men with HGPIN, ASAP, and low-grade prostate cancer. Nutr Cancer. 60(1):7–13. doi:10.1080/01635580701586770.
  • Hong K-W, Ko K-P, Ahn Y, Kim C-S, Park S-J, Park JK, Kim SS, Kim Y. 2012. Epidemiological profiles between equol producers and nonproducers: a genomewide association study of the equol-producing phenotype. Genes Nutr. 7(4):567–574. doi:10.1007/s12263-012-0292-8.
  • Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina MJ, Phipps WR, Cassidy A. 2009. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update. 15(4):423–440. doi:10.1093/humupd/dmp010.
  • Hüser S, Guth S, Joost HG, Soukup ST, Köhrle J, Kreienbrock L, Diel P, Lachenmeier DW, Eisenbrand G, Vollmer G, et al. 2018. Effects of isoflavones on breast tissue and the thyroid hormone system in humans: a comprehensive safety evaluation. Arch Toxicol. 92(9):2703–2748. doi:10.1007/s00204-018-2279-8.
  • Ikeda T, Nishikawa A, Imazawa T, Kimura S, Hirose M. 2000. Dramatic synergism between excess soybean intake and iodine deficiency on the development of rat thyroid hyperplasia. Carcinogenesis. 21(4):707–713. doi:10.1093/carcin/21.4.707.
  • Kelly GE, Nelson C, Waring MA, Joannou GE, Reeder AY. 1993. Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta. 223(1):9–22. doi:10.1016/0009-8981(93)90058-C.
  • Koh E, Mitchell AE. 2011. Characterization of urinary isoflavone metabolites excreted after the consumption of soy flour or soybean paste using Lc-(esi)ms/Ms. J Food Biochem. 35(5):1474–1485. doi:10.1111/j.1745-4514.2010.00469.x.
  • Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S, Study Group JPHC. 2007. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in Japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation. 116(22):2553–2562. doi:10.1161/CIRCULATIONAHA.106.683755.
  • Lee RH, Spencer CA, Mestman JH, Miller EA, Petrovic I, Braverman LE, Goodwin TM. 2009. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol. 200(3):260.e1–260.e6. doi:10.1016/j.ajog.2008.10.042.
  • Lephart ED. 2015. Modulation of aromatase by phytoestrogens. Enzyme Res. doi: 10.1155/2015/594656. [accessed 2018 Nov 5] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4699002/
  • Leung AM, Braverman LE, He X, Schuller KE, Roussilhes A, Jahreis KA, Pearce EN. 2012. Environmental perchlorate and thiocyanate exposures and infant serum thyroid function. Thyroid. 22(9):938–943. doi:10.1089/thy.2012.0058.
  • Liu J, Ho SC, Su Y, Chen W, Zhang C, Chen Y. 2009. Effect of long-term intervention of soy isoflavones on bone mineral density in women: A meta-analysis of randomized controlled trials. Bone. 44(5):948–953. doi:10.1016/j.bone.2008.12.020.
  • Liu J, Yuan F, Gao J, Shan B, Ren Y, Wang H, Gao Y. 2016. Oral isoflavone supplementation on endometrial thickness: a meta-analysis of randomized placebo-controlled trials. Oncotarget. 7(14):17369–17379. doi:10.18632/oncotarget.7959.
  • Lu LJ, Anderson KE. 1998. Sex and long-term soy diets affect the metabolism and excretion of soy isoflavones in humans. Am J Clin Nutr. 68(6):1500S–1504S. doi:10.1093/ajcn/68.6.1500S.
  • Lu LJ, Anderson KE, Grady JJ, Nagamani M. 1996. Effects of soya consumption for one month on steroid hormones in premenopausal women: implications for breast cancer risk reduction. Cancer Epidemiol Biomarkers Prev. 5(1):63–70.
  • Lu L-JW, Anderson KE, Grady JJ, Kohen F, Nagamani M. 2000. Decreased ovarian hormones during a soya diet: implications for breast cancer prevention. Cancer Res. 60(15):4112–4121.
  • Ma D-F, Qin L-Q, Wang P-Y KR. 2008. Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials. Clin Nutr. 27(1):57–64. doi:10.1016/j.clnu.2007.10.012.
  • Marsili A, Zavacki AM, Harney JW, Larsen PR. 2011. Physiological role and regulation of iodothyronine deiodinases: a 2011 update. J Endocrinol Invest. 34(5):395–407. doi: 10.3275/7615.
  • Maskarinec G, Singh S, Meng L, Franke AA. 1998. Dietary soy intake and urinary isoflavone excretion among women from a multiethnic population. Cancer Epidemiol Biomarkers Prev. 7(7):613–619.
  • Meeker JD. 2012. Exposure to environmental endocrine disruptors and child development. Arch Pediatr Adolesc Med. 166(10):952–958. doi:10.1001/archpediatrics.2012.241.
  • Meeker JD, Ferguson KK. 2014. Urinary phthalate metabolites are associated with decreased serum testosterone in men, women, and children from NHANES 2011–2012. J Clin Endocrinol Metab. 99(11):4346–4352. doi:10.1210/jc.2014-2555.
  • Messina M, Redmond G. 2006. Effects of soy protein and soybean isoflavones on thyroid function in healthy adults and hypothyroid patients: a review of the relevant literature. Thyroid. 16(3):249–258. doi:10.1089/thy.2006.16.249.
  • Nagata C, Kabuto M, Kurisu Y, Shimizu H. 1997. Decreased serum estradiol concentration associated with high dietary intake of soy products in premenopausal Japanese women. Nutr Cancer. 29(3):228–233. doi:10.1080/01635589709514629.
  • Nagata C, Takatsuka N, Inaba S, Kawakami N, Shimizu H. 1998. Effect of soymilk consumption on serum estrogen concentrations in premenopausal japanese women. J Natl Cancer Inst. 90(23):1830–1835. doi:10.1093/jnci/90.23.1830.
  • NHANES. 2007. Laboratory Procedures Manual.
  • NHANES. 2009. Laboratory Procedures Manual.
  • O’Brien KM, Upson K, Cook NR, Weinberg CR. 2016. Environmental chemicals in urine and blood: improving methods for creatinine and lipid adjustment. Environ Health Perspect. 124(2):220–227. doi:10.1289/ehp.1509693.
  • Patisaul HB, Jefferson W. 2010. The pros and cons of phytoestrogens. Front Neuroendocrinol. 31(4):400–419. doi:10.1016/j.yfrne.2010.03.003.
  • Pearce EN, Braverman LE. 2009. Environmental pollutants and the thyroid. Best Pract Res Clin Endocrinol Metab. 23(6):801–813. doi:10.1016/j.beem.2009.06.003.
  • Rousset B, Dupuy C, Miot F, Dumont J. 2000. Chapter 2 thyroid hormone synthesis and secretion. In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, et al. editors. Endotext. South Dartmouth (MA): MDText.com, Inc. [accessed 2018 Nov 5] http://www.ncbi.nlm.nih.gov/books/NBK285550/
  • Sacks FM, Lichtenstein A, Horn LJV, Harris WS, Kris-Etherton PM, Winston MC. 2006. Soy protein, isoflavones, and cardiovascular health: an American heart association science advisory for professionals from the nutrition committee. Circulation. 113(7):1034–1044. doi:10.1161/CIRCULATIONAHA.106.171052.
  • Sathyapalan T, Manuchehri AM, Thatcher NJ, Rigby AS, Chapman T, Kilpatrick ES, Atkin SL. 2011. The effect of soy phytoestrogen supplementation on thyroid status and cardiovascular risk markers in patients with subclinical hypothyroidism: a randomized, double-blind, crossover study. J Clin Endocrinol Metab. 96(5):1442–1449. doi:10.1210/jc.2010-2255.
  • Setchell KDR, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. 2001. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr. 131(4):1362S–1375S. doi:10.1093/jn/131.4.1362S.
  • Singh GK, Balzer BW, Desai R, Jimenez M, Steinbeck KS, Handelsman DJ. 2015. Requirement for specific gravity and creatinine adjustments for urinary steroids and luteinizing hormone concentrations in adolescents. Ann Clin Biochem. 52(6):665–671. doi:10.1177/0004563215580385.
  • Soni M, White LR, Kridawati A, Bandelow S, Hogervorst E. 2016. Phytoestrogen consumption and risk for cognitive decline and dementia: with consideration of thyroid status and other possible mediators. J Steroid Biochem Mol Biol. 160:67–77. doi:10.1016/j.jsbmb.2015.10.024.
  • Taku K, Melby MK, Kronenberg F, Kurzer MS, Messina M. 2012. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials. Menopause: J North Am Menopause Soc. 19(7):776–790. doi:10.1097/gme.0b013e3182410159.
  • Tonstad S, Jaceldo-Siegl K, Messina M, Haddad E, Fraser GE. 2016. The association between soya consumption and serum thyroid-stimulating hormone concentrations in the adventist health study-2. Public Health Nutr. 19(8):1464–1470. doi:10.1017/S1368980015002943.
  • US EPA O. 2015 Aug 10. What is endocrine disruption? US EPA. [accessed 2019 Jan 6]. https://www.epa.gov/endocrine-disruption/what-endocrine-disruption.
  • Wang C, Mäkelä T, Hase T, Adlercreutz H, Kurzer MS. 1994. Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol. 50(3):205–212. doi:10.1016/0960-0760(94)90030-2.
  • Watanabe S, Terashima K, Sato Y, Arai S, Eboshida A. 2000. Effects of isoflavone supplement on healthy women. BioFactors. 12(1–4):233–241. doi:10.1002/biof.5520120136.
  • White HL, Freeman LM, Mahony O, Graham Peter A, Hao Q, Court MH. 2004. Effect of dietary soy on serum thyroid hormone concentrations in healthy adult cats. Am J Vet Res. 65(5):586–591. doi:10.2460/ajvr.2004.65.586.
  • Wu A, Stanczyk F, Hendrich S, Murphy P, Zhang C, Wan P, Pike M. 2000. Effects of soy foods on ovarian function in premenopausal women. Br J Cancer. 82(11):1879–1886..
  • Wu AH, Yu MC, Tseng -C-C, Pike MC. 2008. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 98(1):9–14. doi:10.1038/sj.bjc.6604145.
  • Xu X, Duncan AM, Merz BE, Kurzer MS. 1998. Effects of soy isoflavones on estrogen and phytoestrogen metabolism in premenopausal women. Cancer Epidemiol Biomarkers Prev. 7(12):1101–1108.
  • Yuan J-P, Wang J-H LX. 2007. Metabolism of dietary soy isoflavones to equol by human intestinal microflora – implications for health. Mol Nutr Food Res. 51(7):765–781. doi:10.1002/mnfr.200600262.
  • Zhou Y, Alekel DL, Dixon PM, Messina M, Reddy MB. 2011. The effect of soy food intake on mineral status in premenopausal women. J Women’s Health. 20(5):771–780. doi:10.1089/jwh.2010.2491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.